Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A
- PMID: 1427382
- PMCID: PMC1379499
- DOI: 10.1136/gut.33.9.1264
Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A
Abstract
Plasma values of immunoreactive interleukin-6, C-reactive protein and phospholipase A have been determined in serial samples from 24 patients with acute pancreatitis ('mild' pancreatitis nine, 'severe' pancreatitis 15). Median plasma concentrations of interleukin-6, C-reactive protein, and phospholipase A activity were significantly higher in patients with 'severe' illness (p < 0.001) than those with 'mild' illness. A particularly marked increase in interleukin-6 was found in two patients with necrotising pancreatitis and fatal outcome. Significant correlations between plasma concentrations of interleukin-6 and phospholipase A (p = 0.0218) and C-reactive protein and phospholipase A activity (p < 0.0001) were found in patients with 'severe' disease. These findings in a limited number of patients with acute pancreatitis are promising in that raised interleukin-6 correlated with clinical severity and with two other established markers, C-reactive protein, and phospholipase A activity.
Similar articles
-
C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis.Gut. 1987 Jun;28(6):764-71. doi: 10.1136/gut.28.6.764. Gut. 1987. PMID: 3623221 Free PMC article.
-
Serum interleukin 6 in the prognosis of acute biliary pancreatitis.Ital J Gastroenterol Hepatol. 1998 Jun;30(3):291-4. Ital J Gastroenterol Hepatol. 1998. PMID: 9759598
-
Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein.Dig Dis Sci. 1995 Nov;40(11):2341-8. doi: 10.1007/BF02063235. Dig Dis Sci. 1995. PMID: 7587812
-
Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis.Gut. 1993 Jan;34(1):41-5. doi: 10.1136/gut.34.1.41. Gut. 1993. PMID: 7679365 Free PMC article.
-
Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis.Pancreas. 1999 May;18(4):371-7. doi: 10.1097/00006676-199905000-00007. Pancreas. 1999. PMID: 10231842
Cited by
-
Activation of cellular immune response in acute pancreatitis.Gut. 1997 Jun;40(6):794-7. doi: 10.1136/gut.40.6.794. Gut. 1997. PMID: 9245935 Free PMC article.
-
Serum interleukin-10 in human acute pancreatitis.Dig Dis Sci. 1997 Jul;42(7):1469-72. doi: 10.1023/a:1018814710291. Dig Dis Sci. 1997. PMID: 9246048
-
Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.J Gastroenterol. 1996 Oct;31(5):702-9. doi: 10.1007/BF02347620. J Gastroenterol. 1996. PMID: 8887038 Clinical Trial.
-
A Mini-Review on the Effect of Docosahexaenoic Acid (DHA) on Cerulein-Induced and Hypertriglyceridemic Acute Pancreatitis.Int J Mol Sci. 2017 Oct 25;18(11):2239. doi: 10.3390/ijms18112239. Int J Mol Sci. 2017. PMID: 29068376 Free PMC article. Review.
-
Role of Clinical, Biochemical, and Imaging Parameters in predicting the Severity of Acute Pancreatitis.Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):1-5. doi: 10.5005/jp-journals-10018-1202. Epub 2017 May 5. Euroasian J Hepatogastroenterol. 2017. PMID: 29201763 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials